http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2771205-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-582 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-686 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6876 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 |
filingDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48e31b70497a9e1225138cec78ac3ba6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_389f94f0f48171dd4bf9675c670b764c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aa3a6a98f2924d83c1686e60de350e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_477a31eecdb2dd1e575ca5ba1efd55b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95471ba983ed7f88b842c2e99960fbe9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13463d680fe71ea78a8d3e5c3f723ee8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ba0cd89e26f5890c06642ae393532bc |
publicationDate | 2022-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2771205-C1 |
titleOfInvention | QUANTIFICATION OF THE hsa-miR-30c-5/VIM, hsa-miR-28-3p/VIM, hsa-miR-1-3p/ANXA2, hsa-miR-30c-5p/FBN1, hsa-miR-15b-5p/MYL6 tr.v.1, hsa-miR-15b-5p/MYL6 tr.v.2, hsa-miR-185-3p/FLNA, hsa-miR-1-3p/YWHAZ, hsa-miR-30c-5p/YWHAZ AND hsa-miR-654-3p/FGA RATIO IN THE PLACENTAL SITE OF WOMEN ON THE DAY OF DELIVERY AT A TERM OF MORE THAN 34 WEEKS OF GESTATION AS A METHOD FOR DIFFERENTIAL DIAGNOSIS OF FETAL GROWTH RESTRICTION SYNDROME, PREECLAMPSIA AND A SMALL FOR GESTATIONAL AGE FETUS SYNDROME |
abstract | FIELD: medicine. n SUBSTANCE: invention relates to the field of biomedicine, in particular, to obstetrics and molecular biology, and is intended for differential diagnosis of fetal growth restriction syndrome (FGR), preeclampsia (PE), and a small for gestational age fetus syndrome. The hsa-miR-30c-5p/VIM, hsa-miR-28-3p/VIM, hsa-miR-1-3p/ANXA2, hsa-miR-30c-5p/FBN1, hsa-miR-15b-5p/MYL6 tr.v.1, hsa-miR-15b-5p/MYL6 tr.v.2, hsa-miR-185-3p/FLNA, hsa-miR-1-3p/YWHAZ, hsa-miR-30c-5p/YWHAZ and hsa-miR-654-3p/FGA ratio is quantified in the placental site of women on the day of delivery at a term of more than 34 weeks of gestation. Logarithms of the values of said ratios to base two are calculated. Based on the above calculation, FGR, PE and the small for gestational age fetus syndrome are differentiated. n EFFECT: invention ensures verification of the diagnosis made on the basis of clinical and laboratory research methods on the day of delivery to select the optimal management tactics for the mother and the child for the purpose of preventing possible postpartum complications. n 1 cl, 1 dwg, 4 tbl, 1 ex |
priorityDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 250.